Authors


Megan Maroney, PharmD, BCP

Latest:

Serotonin and Beyond: Optimizing Management of Major Depressive Disorder

Pharmacists can learn about treatment of major depressive disorder.


Karen Fiumara, PharmD

Latest:

Medication Use in Bariatric Surgery: Evaluation of Perioperative Adjustments

A retrospective evaluation to assess whether medications for patients undergoing bariatric procedures are effectively optimized to ensure safe medication transitioning.


Jola Mehmeti, PharmD/MBA Candidate 2018

Latest:

A Look at TCA Toxicity Presentation and Treatment

In 2015, American poison centers responded to more than 10,000 tricyclic antidepressant exposures. With this level of prevalence, pharmacists should be prepared to respond to questions regarding TCA toxicity.


Daniel Weiss, Senior Editor

Latest:

Pharmacist Provider Status in Spotlight at APhA Annual Meeting

A number of speakers at the American Pharmacists Association 2014 Annual Meeting in Orlando emphasized the importance of winning provider status for pharmacists.




Jamie Shelly, PharmD

Latest:

Examining Recent Advances in Understanding and Treatment of Dry Eye Disease: An Eye on the Pharmacist's Role

This Continuing Education activity is supported by an educational grant from Alcon, Inc.


Austin Hewlett, PharmD-MBA Candidate

Latest:

Carving Out a Niche in the Treatment of Tardive Dyskinesia

The FDA recently approved Ingrezza (valbenazine) for the treatment of adults with tardive dyskinesia.


Jennifer D. Goldman, RPh, PharmD, CDE, BC-ADM, FCCP

Latest:

Pharmacists and Annual Wellness Visits

Pharmacists are continuing to expand their role as health care providers with more direct patient care opportunities. Pharmacists working under the supervision of a physician can provide an annual wellness visit, which is an exam that focuses on the patient’s health, allowing them the opportunity to develop a personalized approach to health care and disease prevention.



Patricia A. Russo, PhD, MSW, RN

Latest:

Pharmacotherapy Timing in Heart Failure and Impact on Healthcare Costs

The findings of a retrospective study suggest that timing of heart failure (HF)-related pharmacotherapy following a HF-related encounter has potential implications on subsequent healthcare costs.


Mark Herring, PharmD

Latest:

Influenza vs the Common Cold: Symptoms and Treatment

Patients may find it difficult to distinguish between a cold and the flu, and pharmacists can help them determine if self treatment is appropriate.


Troy Trygstad, PharmD, MBA, PhD

Latest:

Pharmacist Provider Status Is Growing. Now What?

Throughout a new graduate’s career, that provider status will become mainstream.


John W. Hanna, MBA

Latest:

Healthcare Utilization and Costs for Insured Patients With Fibromyalgia

Fibromyalgia was related to a pattern of initial increase in utilization and costs, followed by a decrease 7 to 12 months after diagnosis.


Macary Marciniak, PharmD, BCACP, BCPS, FAPhA

Latest:

Adult Immunizations: Are Your Patients Up-to-Date?

In the health-system setting, pharmacists must often prioritize their attention to treating the most acute medical condition a patient presents with; however, it is important to also consider opportunities to prevent disease.


John F. Aforismo, BSc Pharm, RPh

Latest:

Initiating Drug Therapy in Multiple Sclerosis Patients: Effect on Healthcare Costs

Multiple sclerosis (MS) is a disease of inflammatory demyelination of axons of the central nervous system that results in episodes of transient neurologic deficits, progressing to permanent neurologic deterioration over time.1 The cause of MS remains unclear, but it is thought to involve both genetic susceptibility and environmental triggers, possibly viral, which result in self-sustaining autoimmune dysfunction.


Larry King, Surescripts Manager of Clinical Informatics

Latest:

How Zero-Error E-Prescribing Can Help Pharmacists as They Begin COVID-19 Vaccinations

As administration of COVID-19 begins, pharmacies are preparing to vaccinate millions of people, not only once but twice.


Jeff Reichard, PharmD, MS

Latest:

Securing Specialty Oncology Contracts in a Data-Driven World

Data aggregation partners can provide value in their ability to pull clinical information from both the HSSP and electronic health records.


Bea Riemschneider, Group Editorial Director

Latest:

Total Store Expo, Take 2

NACDS anticipates another successful conference in Boston this August.


Contagion Editorial Staff

Latest:

Combo Inhibitor Antibiotic Approved to Treat HABP/VABP

The US Food and Drug Administration has approved Allergan's supplemental New Drug Application to expand the approved use of their cephalosporin / beta-lactamase inhibitor combo antibiotic, AVYCAZ (ceftazidime and avibactam), to include the treatment of hospital-acquired bacterial pneumonia and ventilator-associated bacterial pneumonia (HABP/VABP) caused by the following susceptible Gram-negative microorganisms: Klebsiella pneumoniae, Enterobacter cloacae, Escherichia coli, Serratia marcescens, Proteus mirabilis, Pseudomonas aeruginosa, and Haemophilus influenzae in patients 18 years of age or older.


Bella Pangaribuan, PharmD Candidate

Latest:

New Insulin Products and Best Practices

Even with many new developments over the past century, the coordinated use of blood glucose monitors, diabetes medications, and insulin to manage the disease may be too intricate for some patients.


Phillips S. Owen, BCPS

Latest:

Postoperative Pain Management

Postoperative pain management presents a major challenge to patients and health care providers.



Nana Mainoo, PharmD Candidate

Latest:

Keeping a Healthy Brain in the Midst of COVID-19

In addition to allopathic or prescription medications to manage depression stemming from this pandemic, there are integrative medicines, as well as health and wellness modalities, that can be used to improve mental health.


Dipti Desai, PharmD

Latest:

NAPLEX Preparation: Tips for the Most Important Exam of Your Career

Before you start preparing for NAPLEX, familiarize yourself with what to expect for the exam.



John P. Jameson, PharmD

Latest:

Pharmacist Collaborative Management of Poorly Controlled Diabetes Mellitus: A Randomized Controlled Trial

Diabetes mellitus affects 23 million people in the United States. Adjusting for population age differences, survey data between 2004 and 2006 indicate that 6.6% of non-Hispanic whites, 7.5% of Asian Americans, 10.4% of Hispanics, and 11.8% of non-Hispanic blacks have diabetes mellitus.1 Totaling $174 billion in 2007, diabetes care accounts for 19% of total healthcare costs.


Michele L. Robinson

Latest:

The Impact of Health Care Reform

The 2010 health care reforms affect the daily practices of pharmacists, especially as generic drugs play an even greater role in the cost containment of health care for millions of Americans.



Kevin Cast

Latest:

Cancer Patients Require Coordinated Care

Treatment advances have made many cancers a chronic disease rather than a terminal disease. Here is how one dedicated team works to coordinate care and work with patients.